• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物不良反应。一项在精神病医院开展的流行病学研究。

Adverse drug reactions. An epidemiological study at psychiatric hospitals.

作者信息

Schmidt L G, Grohmann R, Helmchen H, Langscheid-Schmidt K, Müller-Oerlinghausen B, Poser W, Rüther E, Scherer J, Strauss A, Wolf B

出版信息

Acta Psychiatr Scand. 1984 Jul;70(1):77-89. doi: 10.1111/j.1600-0447.1984.tb01185.x.

DOI:10.1111/j.1600-0447.1984.tb01185.x
PMID:6464798
Abstract

A drug monitoring system has been established at psychiatric university hospitals in Berlin, Goettingen, and Munich since 1979 in order to investigate adverse reactions to psychotropic drugs. This report describes the system and presents results obtained over 3 years. 504 randomly selected patients were observed by Intensive Drug Monitoring; 75% of them had an adverse drug reaction (ADR) during hospitalization that was assessed as possible, probable, or definite including all grades (I-III) of severity. 5,096 other patients were monitored by Organized Spontaneous Reporting during treatment with psychotropic drugs: ADRs were responsible for drug withdrawal (severity grade III) in about 10% of them. Parkinsonism, psychomotor disturbance, akathisia, delirium, oversedation and increased transaminases were the most frequent ADRs of this kind. The relative frequency of ADRs was calculated, and ADR-profiles established for drugs most frequently withdrawn. The impact of ADRs on ongoing therapy of patients was assessed. Reliable data obtained by drug monitoring systems can be expected to aid in therapeutic decisions in patients with special risks of side effects to psychotropic drugs.

摘要

自1979年起,柏林、哥廷根和慕尼黑的大学精神病医院建立了一个药物监测系统,以调查精神药物的不良反应。本报告介绍了该系统并展示了3年期间获得的结果。通过强化药物监测观察了504名随机选择的患者;其中75%在住院期间出现了药物不良反应(ADR),这些反应被评估为可能、很可能或肯定,包括所有严重程度等级(I - III级)。另外5096名患者在接受精神药物治疗期间通过有组织的自发报告进行监测:ADR导致约10%的患者停药(严重程度III级)。帕金森症、精神运动障碍、静坐不能、谵妄、过度镇静和转氨酶升高是这类最常见的ADR。计算了ADR的相对频率,并为最常导致停药的药物建立了ADR特征。评估了ADR对患者正在进行的治疗的影响。药物监测系统获得的可靠数据有望有助于对有精神药物副作用特殊风险的患者做出治疗决策。

相似文献

1
Adverse drug reactions. An epidemiological study at psychiatric hospitals.药物不良反应。一项在精神病医院开展的流行病学研究。
Acta Psychiatr Scand. 1984 Jul;70(1):77-89. doi: 10.1111/j.1600-0447.1984.tb01185.x.
2
Assessment of adverse drug reactions in psychiatric hospitals.精神病医院中药物不良反应的评估。
Eur J Clin Pharmacol. 1984;26(6):727-34. doi: 10.1007/BF00541933.
3
Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.精神药物的不良心理反应——AMUP研究报告
Pharmacopsychiatry. 1993 May;26(3):84-93. doi: 10.1055/s-2007-1014348.
4
Psychiatric admissions due to adverse drug reactions.因药物不良反应导致的精神科住院治疗。
Compr Psychiatry. 1989 Nov-Dec;30(6):534-45. doi: 10.1016/0010-440x(89)90084-9.
5
The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.精神科药物监测的AMUP研究——住院患者数据总结
Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S16-26. doi: 10.1055/s-2004-815507.
6
Are non-serious adverse reactions to psychiatric drugs really non-serious?精神科药物的非严重不良反应真的不严重吗?
J Child Adolesc Psychopharmacol. 2013 Aug;23(6):394-400. doi: 10.1089/cap.2012.0094.
7
Transfer of psychiatric inpatients to a general hospital due to adverse drug reactions.因药物不良反应将精神科住院患者转至综合医院。
Psychosomatics. 1997 Jan-Feb;38(1):35-7. doi: 10.1016/s0033-3182(97)71501-9.
8
The AMSP drug safety program: methods and global results.AMSP药物安全项目:方法与全球结果。
Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S4-11. doi: 10.1055/s-2004-815505.
9
Cardiac adverse effects associated with psychotropic drugs.与精神药物相关的心脏不良反应。
Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S65-9. doi: 10.1055/s-2004-815512.
10
Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.一家三级护理医院的药品不良反应的发生率、类型、严重程度、可预防性及成本
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:323-34. doi: 10.1016/j.vascn.2016.04.011. Epub 2016 Apr 20.

引用本文的文献

1
Adverse Drug Reaction Monitoring in a Tertiary Care Psychiatry Setting: A Comparative Study between Inpatients and Outpatients.三级医疗精神病学环境中的药物不良反应监测:住院患者与门诊患者的比较研究
Indian J Psychol Med. 2017 May-Jun;39(3):306-311. doi: 10.4103/0253-7176.207328.
2
Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.上市后药品安全性监测的IV期临床试验概述:来自ClinicalTrials.gov注册库的现状报告
BMJ Open. 2016 Nov 23;6(11):e010643. doi: 10.1136/bmjopen-2015-010643.
3
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country.
发展中国家精神药物药物警戒的前瞻性监测
Psychopharmacol Bull. 2016 Mar 1;46(1):54-66.
4
The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.日本精神科住院患者药物不良事件和用药错误的流行病学:JADE研究
BMC Psychiatry. 2016 Aug 30;16(1):303. doi: 10.1186/s12888-016-1009-0.
5
Adverse drug reactions: a retrospective review of hospitalized patients at a state psychiatric hospital.药物不良反应:对一家州立精神病医院住院患者的回顾性研究
Hosp Pharm. 2013 Dec;48(11):931-5. doi: 10.1310/hpj4811-931.
6
Incidence of adverse reactions to commonly prescribed psychopharmacological agents during early phase of therapy.治疗早期常见精神药理学药物不良反应的发生率。
Indian J Psychiatry. 1995 Jul;37(3):113-8.
7
Assessment of adverse drug reactions in psychiatric hospitals.精神病医院中药物不良反应的评估。
Eur J Clin Pharmacol. 1984;26(6):727-34. doi: 10.1007/BF00541933.
8
Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.精神病医院药物不良反应评估的一致性:算法方法与经验方法的比较
Eur J Clin Pharmacol. 1986;30(2):199-204. doi: 10.1007/BF00614303.
9
Reliability of adverse drug reaction assessment in psychiatric inpatients.精神科住院患者药物不良反应评估的可靠性
Eur Arch Psychiatry Neurol Sci. 1985;235(3):158-63. doi: 10.1007/BF00380987.
10
Adverse effects of clozapine.氯氮平的不良反应。
Psychopharmacology (Berl). 1989;99 Suppl:S101-4. doi: 10.1007/BF00442571.